Ideas & Insights

Data tells the story: Technology and software M&A remains historically healthy, as high prices affect volume to a degree.

In challenging sellers’ market for life sciences and medical devices, private equity firms and strategics vie competitively.

Both deal count and value are projected for an annual decrease giving fuel to the speculation that PE interest in retail is trending down.

A panel of private equity deal experts discuss the trends behind the deal statistics and outcomes from Q3 2018.

Watch and learn the impact of the tax changes on mergers and acquisitions and the type of entity that stands to be most affected.

From evolving regulatory needs to operations, understand the key due diligence considerations when acquiring a technology company.

In this issue of the private equity CFO conversation series, we look at why CFOs must expand beyond their traditional role.

As health care M&A continues to grow and thrive, what are the key transaction considerations for investors? Learn the top trends.

How FFL Partners developed and executed a plan to improve a business facing a highly challenging but opportune market.

What are the unique health care-specific issues related to personal information and data privacy that every investor should understand

How can technology improve the health care industry by streamlining processes and creating efficiencies, improving the patient experience?

Because competition is fierce, understanding strategic fit is key to ensuring returns on your life sciences and medical device investment.

Learn ways to successfully run a smooth sale and achieve capital growth in the health care industry by implementing the right strategies.

Increased adoption of technology and the ability to adapt in the face of regulatory pressures will be top of mind for health care

The ceaseless rise of equities continues to fuel M&A among technology companies; however, multiples remain high

With consumer preferences changing, the consumer industry continues to evolve to meet the new requirements of an on-demand economy.

Slowing M&A activity may be due to hesitation around new trade policies and how they may influence strategic directions of organizations.

The newly enacted omnibus spending bill brings both opportunity and uncertainty for business development companies. Learn why.

With a maturing business development company (BDC) sector, the competition for investor attention and capital is mounting.

What’s the early impact of tariffs? Commentary on economic conditions reveals evidence of rising input costs and general trade anxiety.